Canada - anglais - Health Canada

apotex inc - megestrol acetate - tablet - 160mg - megestrol acetate 160mg - antineoplastic agents

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

apotex nz ltd - megestrol acetate 160mg - tablet - 160 mg - active: megestrol acetate 160mg excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - apo-megestrol is indicated for the palliative treatment of advanced carcinoma of the breast or endometrium (i.e. recurrent, inoperable or metastatic diseases). it should not be used in lieu of currently accepted procedures such as surgery, radiation or chemotherapy. apo-megestrol is indicated for the treatment of anorexia, cachexia, or a significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (aids).

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

apotex nz ltd - megestrol acetate 40mg - tablet - 40 mg - active: megestrol acetate 40mg excipient: brilliant blue fcf colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - apo-megestrol is indicated for the palliative treatment of advanced carcinoma of the breast or endometrium (i.e. recurrent, inoperable or metastatic diseases). it should not be used in lieu of currently accepted procedures such as surgery, radiation or chemotherapy. apo-megestrol is indicated for the treatment of anorexia, cachexia, or a significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (aids).

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - dienestrol 0.01% - vaginal cream - 0.01 % - active: dienestrol 0.01% excipient: arachis oil benzoic acid butylated hydroxyanisole citric acid monohydrate glutamic acid glycerol glyceryl monostearate purified water sodium hydroxide

Canada - anglais - Health Canada

ortho pharmaceutical, division of janssen-ortho inc. - dienestrol - cream - .01% - dienestrol .01% - estrogens

États-Unis - anglais - NLM (National Library of Medicine)

stat rx usa - megestrol acetate (unii: tj2m0fr8es) (megestrol - unii:ea6ld1m70m) - megestrol acetate 125 mg in 1 ml - megace ® es (megestrol acetate) oral suspension is indicated for the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (aids). history of hypersensitivity to megestrol acetate or any component of the formulation. known or suspected pregnancy.

États-Unis - anglais - NLM (National Library of Medicine)

pharmaceutical associates, inc. - megestrol acetate (unii: tj2m0fr8es) (megestrol - unii:ea6ld1m70m) - megestrol acetate oral suspension is indicated for the treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (aids). limitations of use therapy with megestrol acetate for weight loss should only be instituted after treatable causes of weight loss are sought and addressed. these treatable causes include possible malignancies, systemic infections, gastrointestinal disorders affecting absorption, endocrine disease, renal disease or psychiatric diseases. megestrol acetate is not intended for prophylactic use to avoid weight loss. - history of hypersensitivity to megestrol acetate or any component of the formulation. - pregnancy [see warnings and precautions (5.2), use in specific populations (8.1, 8.3)] . risk summary based on animal data, megestrol ac

États-Unis - anglais - NLM (National Library of Medicine)

avera mckennan hospital - megestrol acetate (unii: tj2m0fr8es) (megestrol - unii:ea6ld1m70m) - megestrol acetate 40 mg

États-Unis - anglais - NLM (National Library of Medicine)

cardinal health - megestrol acetate (unii: tj2m0fr8es) (megestrol - unii:ea6ld1m70m) - megestrol acetate 40 mg

États-Unis - anglais - NLM (National Library of Medicine)

breckenridge pharmaceutical, inc. - megestrol acetate (unii: tj2m0fr8es) (megestrol - unii:ea6ld1m70m) - megestrol acetate oral suspension is indicated for the treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (aids). limitations of use therapy with megestrol acetate for weight loss should only be instituted after treatable causes of weight loss are sought and addressed. these treatable causes include possible malignancies, systemic infections, gastrointestinal disorders affecting absorption, endocrine disease, renal disease or psychiatric diseases. megestrol acetate is not intended for prophylactic use to avoid weight loss. - history of hypersensitivity to megestrol acetate or any component of the formulation. - pregnancy [see warnings and precautions (5.2), use in specific populations (8.1, 8.3)]. risk summary based on animal data, megestrol acetate may cause fetal harm when administered to a pregnant woman and is contraindicated during pregnancy [see contraindications (4)]. there are no available human data to assess